By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Diagnostics firm China Medical Technologies today said its molecular diagnostics sales rose nearly 33 percent year over year in its fiscal second quarter, helping to grow overall revenues about 22 percent.

For the three months ended Sept. 30, the Beijing firm's molecular diagnostics systems segment recorded revenues of RMB118.3 million ($17.8 million), compared to RMB89.2 million in the second quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.